Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Furosemide for Air Hunger Relief (FurAH-II)
NCT04130815Phase 1Unknown
- Sponsor
- Oxford Brookes University
- Start
- Oct 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of furosemide in Dyspnea (4 arms), sponsored by Oxford Brookes University. Primary endpoint: Visual analogue scale for air hunger. Status: unknown.
02
Drugs
furosemide
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT04130815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04130815.